Total Payments
$45,965
2024 Payments
$460.13
Companies
18
Transactions
90
Medicare Patients
486
Medicare Billing
$165,264
Payment Breakdown by Category
Consulting$21,668 (47.1%)
Travel$15,823 (34.4%)
Food & Beverage$5,475 (11.9%)
Other$2,925 (6.4%)
Education$74.99 (0.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $21,668 | 9 | 47.1% |
| Travel and Lodging | $15,823 | 14 | 34.4% |
| Food and Beverage | $5,475 | 64 | 11.9% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,925 | 1 | 4.2% |
| Honoraria | $1,000 | 1 | 2.2% |
| Education | $74.99 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Chugai Pharmaceutical Co., Ltd. | $14,888 | 4 | $0 (2018) |
| Janssen Scientific Affairs, LLC | $12,139 | 19 | $0 (2024) |
| Blue Earth Diagnostics Limited | $6,624 | 12 | $0 (2024) |
| PFIZER INC. | $5,702 | 12 | $0 (2023) |
| Ethicon Inc. | $2,525 | 1 | $0 (2022) |
| Provepharm Inc. | $1,080 | 2 | $0 (2023) |
| Janssen Biotech, Inc. | $929.59 | 12 | $0 (2024) |
| GENZYME CORPORATION | $668.78 | 9 | $0 (2019) |
| Astellas Pharma US Inc | $510.58 | 6 | $0 (2022) |
| Boston Scientific Corporation | $259.60 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $460.13 | 5 | Janssen Biotech, Inc. ($161.57) |
| 2023 | $8,864 | 14 | PFIZER INC. ($4,700) |
| 2022 | $9,515 | 15 | Janssen Scientific Affairs, LLC ($4,512) |
| 2021 | $298.71 | 3 | PFIZER INC. ($279.48) |
| 2020 | $425.44 | 5 | Astellas Pharma US Inc ($263.98) |
| 2019 | $5,527 | 20 | Janssen Scientific Affairs, LLC ($2,362) |
| 2018 | $18,124 | 20 | Chugai Pharmaceutical Co., Ltd. ($14,888) |
| 2017 | $2,751 | 8 | Blue Earth Diagnostics Limited ($2,466) |
All Payment Transactions
90 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/01/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $154.87 | General |
| Category: Oncology | ||||||
| 04/12/2024 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $136.08 | General |
| 01/25/2024 | Blue Earth Diagnostics Limited | POSLUMA (Drug) | Food and Beverage | In-kind items and services | $29.39 | General |
| Category: Diagnostic Imaging | ||||||
| 01/25/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $6.70 | General |
| Category: Oncology | ||||||
| 01/11/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $133.09 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,340.00 | General |
| 11/28/2023 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 11/16/2023 | Janssen Scientific Affairs, LLC | AKEEGA (Drug) | Food and Beverage | In-kind items and services | $146.57 | General |
| Category: Oncology | ||||||
| 10/20/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $31.45 | General |
| Category: Oncology | ||||||
| 09/11/2023 | PFIZER INC. | ORGOVYX (Drug) | Consulting Fee | Cash or cash equivalent | $4,410.00 | General |
| Category: ONCOLOGY | ||||||
| 09/07/2023 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $139.60 | General |
| Category: General - Erectile Dysfunction_URO | ||||||
| 09/06/2023 | Provepharm Inc. | BLUDIGO (Drug) | Food and Beverage | Cash or cash equivalent | $80.03 | General |
| Category: MARKER DYE | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Travel and Lodging | In-kind items and services | $254.81 | General |
| Category: ONCOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $35.08 | General |
| Category: ONCOLOGY | ||||||
| 07/14/2023 | Provepharm Inc. | BLUDIGO (Drug) | Honoraria | Cash or cash equivalent | $1,000.00 | General |
| Category: MARKER DYE | ||||||
| 06/02/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $127.18 | General |
| Category: Oncology | ||||||
| 05/11/2023 | Blue Earth Diagnostics Limited | Axumin (Drug) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Diagnostic Imaging | ||||||
| 03/31/2023 | Janssen Biotech, Inc. | ERLEADA (Drug), BALVERSA | Food and Beverage | In-kind items and services | $135.23 | General |
| Category: Oncology | ||||||
| 02/17/2023 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $5.05 | General |
| Category: Oncology | ||||||
| 12/07/2022 | Janssen Scientific Affairs, LLC | — | Consulting Fee | Cash or cash equivalent | $2,340.00 | General |
| 11/29/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $129.99 | General |
| 11/29/2022 | Janssen Scientific Affairs, LLC | — | Food and Beverage | In-kind items and services | $20.00 | General |
| 10/28/2022 | PFIZER INC. | XTANDI (Drug), ORGOVYX | Food and Beverage | In-kind items and services | $99.89 | General |
| Category: ONCOLOGY | ||||||
| 08/29/2022 | Ethicon Inc. | — | Consulting Fee | Cash or cash equivalent | $2,525.00 | General |
| 06/18/2022 | Ethicon US, LLC | Enseal X1 (Device), Echelon Flex | Food and Beverage | In-kind items and services | $56.38 | General |
| Category: Energy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 102 | 102 | $352,315 | $28,337 |
| 2022 | 4 | 129 | 129 | $457,970 | $42,477 |
| 2021 | 4 | 132 | 132 | $505,705 | $48,254 |
| 2020 | 4 | 123 | 123 | $510,692 | $46,196 |
Total Patients
486
Total Services
486
Medicare Billing
$165,264
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 17 | 17 | $199,167 | $16,487 | 8.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 56 | 56 | $31,560 | $7,387 | 23.4% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2023 | 12 | 12 | $113,834 | $3,220 | 2.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 17 | 17 | $7,754 | $1,243 | 16.0% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2022 | 21 | 21 | $237,121 | $24,736 | 10.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 75 | 75 | $40,362 | $10,946 | 27.1% |
| 38571 | Removal of lymph nodes of both sides of pelvis using an endoscope | Facility | 2022 | 19 | 19 | $173,744 | $5,457 | 3.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 14 | 14 | $6,743 | $1,339 | 19.9% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2021 | 25 | 25 | $267,963 | $29,902 | 11.2% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 74 | 74 | $38,504 | $11,158 | 29.0% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2021 | 22 | 22 | $193,970 | $6,069 | 3.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 11 | 11 | $5,268 | $1,126 | 21.4% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2020 | 25 | 25 | $259,965 | $29,842 | 11.5% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 58 | 58 | $29,128 | $8,039 | 27.6% |
| 38571 | Removal of total lymph nodes of both sides of pelvis using an endoscope | Facility | 2020 | 24 | 24 | $213,130 | $6,742 | 3.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 16 | 16 | $8,469 | $1,572 | 18.6% |
About Dr. Brian Chapin, MD
Dr. Brian Chapin, MD is a Urology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/27/2007. The National Provider Identifier (NPI) number assigned to this provider is 1104952571.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Chapin, MD has received a total of $45,965 in payments from pharmaceutical and medical device companies, with $460.13 received in 2024. These payments were reported across 90 transactions from 18 companies. The most common payment nature is "Consulting Fee" ($21,668).
As a Medicare-enrolled provider, Chapin has provided services to 486 Medicare beneficiaries, totaling 486 services with total Medicare billing of $165,264. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Urology
- Location Houston, TX
- Active Since 02/27/2007
- Last Updated 07/03/2012
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1104952571
Products in Payments
- Non-Covered Product (Drug) $14,888
- Erleada (Drug) $5,130
- ORGOVYX (Drug) $4,730
- Axumin (Drug) $4,653
- ERLEADA (Drug) $2,594
- BLUDIGO (Drug) $1,080
- XTANDI (Drug) $891.15
- NO PRODUCT DISCUSSED (Drug) $668.78
- PADCEV (Drug) $152.19
- AKEEGA (Drug) $146.57
- LIBTAYO (Biological) $133.09
- EXPAREL (Drug) $126.22
- AMS (Device) $120.00
- Da Vinci Surgical System (Device) $117.65
- ECHELON FLEX Stapler (Device) $108.34
- ZYTIGA (Drug) $96.85
- SUTENT (Drug) $79.27
- Xtandi (Drug) $59.19
- Enseal X1 (Device) $56.38
- POSLUMA (Drug) $29.39
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Houston
Donald Griffith, Md, MD
Urology — Payments: $954,139
Urology $954,139
Mohit Khera, M.d, M.D
Urology — Payments: $412,879
Urology $412,879
Dr. Jonathan Clavell Hernandez, Md, MD
Urology — Payments: $402,131
Urology $402,131
Ashish Kamat, M.d, M.D
Urology — Payments: $395,016
Urology $395,016
Run Wang, M.d, M.D
Urology — Payments: $277,432
Urology $277,432
Ouida Westney, M.d, M.D
Urology — Payments: $250,571
Urology $250,571